Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Titles
NEW
 Top 50 Non-Healthcare Titles
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Congenital Diaphragmatic Hernia Drugs Global Market Report 2025
Request Sample Buy Now
Global Congenital Diaphragmatic Hernia Drugs Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Congenital Diaphragmatic Hernia Drugs Global Market Report 2025

By Type (Posterolateral Bochdalek Hernia, Anterior Morgagni Hernia, Hiatal Hernia), By Treatment (Extracorporeal Membrane Oxygenation, Other Treatments), By Diagnosis (Prenatal, Postnatal), By End-User (Hospitals, Homecare, Specialty Clinics, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Congenital Diaphragmatic Hernia Drugs Market Overview

• Congenital Diaphragmatic Hernia Drugs market size has reached to $4.38 billion in 2024

• Expected to grow to $6.25 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%

• Growth Driver: Elevated Birth Defect Rates Fuel Growth In The Congenital Diaphragmatic Hernia Drug Market

• Market Trend: Innovative Coating Technology Revolutionizes Congenital Diaphragmatic Hernia Treatment

• North America was the largest region in 2024.

What Is Covered Under Congenital Diaphragmatic Hernia Drugs Market?

Congenital diaphragmatic hernia (CDH) is a rare condition that occurs when there is a hole in the diaphragm, the muscle that separates the chest from the abdomen. Congenital diaphragmatic hernia (CDH) drugs refer to the Medications used in the treatment of Congenital diaphragmatic hernia and help reduce the severity of the disease and manage the symptoms and complications associated with the disease.

The main types of congenital diaphragmatic hernia drugs are posterolateral bochdalek hernia, anterior morgagni hernia and hiatal hernia. Posterolateral bochdalek hernia is a type of congenital diaphragmatic hernia, where an opening or defect in the back part of the diaphragm allows abdominal organs to move into the chest cavity. The various types of treatment include extracorporeal membrane oxygenation and others through various diagnoses such as prenatal and postnatal. These are used by various end-users such as hospitals, homecare, specialty clinics and others.

Congenital Diaphragmatic Hernia Drugs Market Size and growth rate 2025 to 2029: Graph

What Is The Congenital Diaphragmatic Hernia Drugs Market Size 2025 And Growth Rate?

The congenital diaphragmatic hernia drugs market size has grown strongly in recent years. It will grow from $4.38 billion in 2024 to $4.69 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to high incidence of congenital diaphragmatic hernia cases, increasing awareness of congenital diaphragmatic hernia, government initiatives.

What Is The Congenital Diaphragmatic Hernia Drugs Market Growth Forecast?

The congenital diaphragmatic hernia drugs market size is expected to see strong growth in the next few years. It will grow to $6.25 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to growing healthcare expenditure, rare disease incentives, growing patient advocacy groups, regenerative medicine, targeted therapies. Major trends in the forecast period include advancements in medical research, advancements in drug development, advances in fetal surgery, pharmacological lung growth, increasing use of personalized medicine, development of new and innovative drug delivery systems, digital health technologies.

The forecast of 7.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. neonatal ICUs by increasing the cost of specialized pulmonary hypertension medications for congenital diaphragmatic hernia treatment sourced from France and Belgium, thereby delaying critical infant care and elevating pediatric critical care expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Congenital Diaphragmatic Hernia Drugs Market Segmented?

1) By Type: Posterolateral Bochdalek Hernia, Anterior Morgagni Hernia, Hiatal Hernia

2) By Treatment: Extracorporeal Membrane Oxygenation, Other Treatments

3) By Diagnosis: Prenatal, Postnatal

4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Posterolateral Bochdalek Hernia: Surgical Interventions, Medications for Symptoms

2) By Anterior Morgagni Hernia: Surgical Interventions, Medications for Symptoms

3) By Hiatal Hernia: Surgical Interventions, Medications

What Is Driving The Congenital Diaphragmatic Hernia Drugs Market? Elevated Birth Defect Rates Fuel Growth In The Congenital Diaphragmatic Hernia Drug Market

The rising birth defects rate is expected to propel the growth of the congenital diaphragmatic hernia drug market. Birth defects refer to structural or functional abnormalities present at birth that can affect the baby's overall health and development. The treatment for congenital diaphragmatic hernia provides prenatal screening, genetic counseling and targeted therapies that lower the occurrence of birth defects due to congenital diaphragmatic hernia and improve the potential for early intervention and personalized care, enhancing the overall well-being and quality of life of affected individuals. For instance, in March 2023, according to the World Health Organization (WHO), a US-based intergovernmental organization, annually, approximately 8 million infants are born with birth defects, with low- and middle-income nations accounting for 9 out of 10 significant problems. Further, an estimated 240,000 newborns die worldwide within 28 days of birth each year due to congenital disorders. Therefore, the rising birth defect rate drives the congenital diaphragmatic hernia drug industry.

What Is Driving The Congenital Diaphragmatic Hernia Drugs Market? Increasing Incidence Of Congenital Diaphragmatic Hernia (CDH)

The increasing incidence of congenital diaphragmatic hernia (CDH) is expected to drive the growth of the congenital diaphragmatic hernia drug market. Congenital diaphragmatic hernia (CDH) is a birth defect that occurs when there is an abnormal opening or hole in the diaphragm, the muscle that separates the chest cavity from the abdominal cavity. These medications may lead to better results for CDH patients overall, as well as improved lung function and decreased pulmonary hypertension. For instance, in October 2022, according to the Cleveland Clinic, a US-based non-profit academic medical center, 1 in 2,500 to 3,500 live births resulted in a congenital diaphragmatic hernia. According to reports, between 70% and 90% of infants who are diagnosed with CDH survive. Therefore, the increasing incidence of congenital diaphragmatic hernia (CDH) drives the growth of the congenital diaphragmatic hernia drug industry.

Who Are The Major Players In The Global Congenital Diaphragmatic Hernia Drugs Market?

Major companies operating in the congenital diaphragmatic hernia drugs market are Pfizer Inc., Johnson and Johnson Limited, Merck and Co. Inc., AbbVie Inc., Novartis AG, GlaxoSmithKline PLC, Medtronic PLC, Amgen Inc., Becton, Dickinson and Company, Viatris Inc., B. Braun SE, Sun Pharmaceutical Industries Ltd., C.R. Bard Inc., W. L. Gore & Associates, Chiesi Farmaceutici S.p.A., Getinge AB, Ferring Pharmaceuticals, Mallinckrodt Pharmaceuticals, Integra LifeSciences Corporation, Genentech Inc., LifeCell International Private Limited, Cook Biotech Inc., Cousin Biotech SAS, Dipro Medical Devices S.R.L., Aspide Medical.

What Are The Key Trends Of The Global Congenital Diaphragmatic Hernia Drugs Market? Innovative Coating Technology Revolutionizes Congenital Diaphragmatic Hernia Treatment

Major companies operating in the congenital diaphragmatic hernia (CDH) market are introducing advancements in treatment procedures with coating technology to sustain their position in the market. Coating technology for drug-embedded synthetic hernia mesh involves the application of a specialized layer or coating onto the surface of a synthetic mesh used for hernia repair. For instance, in April 2022, Ariste Medical, a US-based pre-commercial drug and device company, received U.S. Food and Drug Administration (FDA) clearance to market its drug-embedded synthetic hernia mesh, which aims to reduce the risk of microbial colonization during surgical implantation. The mesh combines the benefits of polypropylene mesh with a biocompatible coating that allows antibiotic residence to mitigate bacterial colonization. This coating technology can be used for implantable and non-implantable devices and has shown potential in materials like polyurethane and ePTFE. Ariste Medical's coating technology could also be applied to ePTFE surgical implants, such as hernia repair surgeries.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Congenital Diaphragmatic Hernia Drugs Market? Juno Pharmaceuticals Acquires Omega Laboratories To Strengthen Market Position

In May 2023, Juno Pharmaceuticals, a Canada-based pharmaceutical company, acquired Omega Laboratories Inc. for an undisclosed amount. This acquisition establishes Juno as the largest specialty generic injectable business in Canada, enhancing its capacity to improve drug supply in the sector. The merger aims to provide better access to essential injectable medications, significantly strengthening Juno's position in the specialty pharmaceutical sector. Omega Laboratories Inc. is a US-based drug testing laboratory that produce medications that support the management of conditions related to congenital diaphragmatic hernia.

Regional Outlook For The Global Congenital Diaphragmatic Hernia Drugs Market

North America was the largest region in the congenital diaphragmatic hernia drugs market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Congenital Diaphragmatic Hernia Drugs Market?

The congenital diaphragmatic hernia drugs market consists of revenues earned by entities by providing surgical treatments and medical interventions. The market value includes the value of related goods sold by the service provider or included within the service offering. The congenital diaphragmatic hernia drug market also includes sales of pain management medications, antibiotics, vasoactive agents, dobutamine and milrinone. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Congenital Diaphragmatic Hernia Drugs Industry?

The congenital diaphragmatic hernia drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the congenital diaphragmatic hernia drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Congenital Diaphragmatic Hernia Drugs Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $4.69 billion
Revenue Forecast In 2034 $6.25 billion
Growth Rate CAGR of 7.4% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Posterolateral Bochdalek Hernia, Anterior Morgagni Hernia, Hiatal Hernia
2) By Treatment: Extracorporeal Membrane Oxygenation, Other Treatments
3) By Diagnosis: Prenatal, Postnatal
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End Users Subsegments: 1) By Posterolateral Bochdalek Hernia: Surgical Interventions, Medications for Symptoms
2) By Anterior Morgagni Hernia: Surgical Interventions, Medications for Symptoms
3) By Hiatal Hernia: Surgical Interventions, Medications
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson and Johnson Limited, Merck and Co. Inc., AbbVie Inc., Novartis AG, GlaxoSmithKline Plc, Medtronic plc, Amgen Inc., Becton, Dickinson and Company, Viatris Inc., B. Braun SE, Sun Pharmaceutical Industries Ltd., C.R. Bard Inc., W. L. Gore & Associates, Chiesi Farmaceutici S.p.A., Getinge AB, Ferring Pharmaceuticals, Mallinckrodt Pharmaceuticals, Integra LifeSciences Corporation, Genentech Inc., LifeCell International Private Limited, Cook Biotech Inc., Cousin Biotech SAS, Dipro Medical Devices S.R.L., Aspide Medical
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Congenital Diaphragmatic Hernia Drugs Market Characteristics

3. Congenital Diaphragmatic Hernia Drugs Market Trends And Strategies

4. Congenital Diaphragmatic Hernia Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Congenital Diaphragmatic Hernia Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Congenital Diaphragmatic Hernia Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Congenital Diaphragmatic Hernia Drugs Market Growth Rate Analysis

5.4. Global Congenital Diaphragmatic Hernia Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Congenital Diaphragmatic Hernia Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Congenital Diaphragmatic Hernia Drugs Total Addressable Market (TAM)

6. Congenital Diaphragmatic Hernia Drugs Market Segmentation

6.1. Global Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Posterolateral Bochdalek Hernia

Anterior Morgagni Hernia

Hiatal Hernia

6.2. Global Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Extracorporeal Membrane Oxygenation

Other Treatments

6.3. Global Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prenatal

Postnatal

6.4. Global Congenital Diaphragmatic Hernia Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare

Specialty Clinics

Other End Users

6.5. Global Congenital Diaphragmatic Hernia Drugs Market, Sub-Segmentation Of Posterolateral Bochdalek Hernia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Surgical Interventions

Medications for Symptoms

6.6. Global Congenital Diaphragmatic Hernia Drugs Market, Sub-Segmentation Of Anterior Morgagni Hernia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Surgical Interventions

Medications for Symptoms

6.7. Global Congenital Diaphragmatic Hernia Drugs Market, Sub-Segmentation Of Hiatal Hernia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Surgical Interventions

Medications

7. Congenital Diaphragmatic Hernia Drugs Market Regional And Country Analysis

7.1. Global Congenital Diaphragmatic Hernia Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Congenital Diaphragmatic Hernia Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Congenital Diaphragmatic Hernia Drugs Market

8.1. Asia-Pacific Congenital Diaphragmatic Hernia Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Congenital Diaphragmatic Hernia Drugs Market

9.1. China Congenital Diaphragmatic Hernia Drugs Market Overview

9.2. China Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Congenital Diaphragmatic Hernia Drugs Market

10.1. India Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Congenital Diaphragmatic Hernia Drugs Market

11.1. Japan Congenital Diaphragmatic Hernia Drugs Market Overview

11.2. Japan Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Congenital Diaphragmatic Hernia Drugs Market

12.1. Australia Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Congenital Diaphragmatic Hernia Drugs Market

13.1. Indonesia Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Congenital Diaphragmatic Hernia Drugs Market

14.1. South Korea Congenital Diaphragmatic Hernia Drugs Market Overview

14.2. South Korea Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Congenital Diaphragmatic Hernia Drugs Market

15.1. Western Europe Congenital Diaphragmatic Hernia Drugs Market Overview

15.2. Western Europe Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Congenital Diaphragmatic Hernia Drugs Market

16.1. UK Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Congenital Diaphragmatic Hernia Drugs Market

17.1. Germany Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Congenital Diaphragmatic Hernia Drugs Market

18.1. France Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Congenital Diaphragmatic Hernia Drugs Market

19.1. Italy Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Congenital Diaphragmatic Hernia Drugs Market

20.1. Spain Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Congenital Diaphragmatic Hernia Drugs Market

21.1. Eastern Europe Congenital Diaphragmatic Hernia Drugs Market Overview

21.2. Eastern Europe Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Congenital Diaphragmatic Hernia Drugs Market

22.1. Russia Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Congenital Diaphragmatic Hernia Drugs Market

23.1. North America Congenital Diaphragmatic Hernia Drugs Market Overview

23.2. North America Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Congenital Diaphragmatic Hernia Drugs Market

24.1. USA Congenital Diaphragmatic Hernia Drugs Market Overview

24.2. USA Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Congenital Diaphragmatic Hernia Drugs Market

25.1. Canada Congenital Diaphragmatic Hernia Drugs Market Overview

25.2. Canada Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Congenital Diaphragmatic Hernia Drugs Market

26.1. South America Congenital Diaphragmatic Hernia Drugs Market Overview

26.2. South America Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Congenital Diaphragmatic Hernia Drugs Market

27.1. Brazil Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Congenital Diaphragmatic Hernia Drugs Market

28.1. Middle East Congenital Diaphragmatic Hernia Drugs Market Overview

28.2. Middle East Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Congenital Diaphragmatic Hernia Drugs Market

29.1. Africa Congenital Diaphragmatic Hernia Drugs Market Overview

29.2. Africa Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Congenital Diaphragmatic Hernia Drugs Market Competitive Landscape And Company Profiles

30.1. Congenital Diaphragmatic Hernia Drugs Market Competitive Landscape

30.2. Congenital Diaphragmatic Hernia Drugs Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson and Johnson Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Congenital Diaphragmatic Hernia Drugs Market Other Major And Innovative Companies

31.1. GlaxoSmithKline Plc

31.2. Medtronic plc

31.3. Amgen Inc.

31.4. Becton, Dickinson and Company

31.5. Viatris Inc.

31.6. B. Braun SE

31.7. Sun Pharmaceutical Industries Ltd.

31.8. C.R. Bard Inc.

31.9. W. L. Gore & Associates

31.10. Chiesi Farmaceutici S.p.A.

31.11. Getinge AB

31.12. Ferring Pharmaceuticals

31.13. Mallinckrodt Pharmaceuticals

31.14. Integra LifeSciences Corporation

31.15. Genentech Inc.

32. Global Congenital Diaphragmatic Hernia Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Congenital Diaphragmatic Hernia Drugs Market

34. Recent Developments In The Congenital Diaphragmatic Hernia Drugs Market

35. Congenital Diaphragmatic Hernia Drugs Market High Potential Countries, Segments and Strategies

35.1 Congenital Diaphragmatic Hernia Drugs Market In 2029 - Countries Offering Most New Opportunities

35.2 Congenital Diaphragmatic Hernia Drugs Market In 2029 - Segments Offering Most New Opportunities

35.3 Congenital Diaphragmatic Hernia Drugs Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Congenital Diaphragmatic Hernia Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Congenital Diaphragmatic Hernia Drugs Market, Sub-Segmentation Of Posterolateral Bochdalek Hernia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Congenital Diaphragmatic Hernia Drugs Market, Sub-Segmentation Of Anterior Morgagni Hernia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Congenital Diaphragmatic Hernia Drugs Market, Sub-Segmentation Of Hiatal Hernia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Congenital Diaphragmatic Hernia Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Congenital Diaphragmatic Hernia Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Pfizer Inc. Financial Performance
  • Table 79: Johnson and Johnson Limited Financial Performance
  • Table 80: Merck and Co. Inc. Financial Performance
  • Table 81: AbbVie Inc. Financial Performance
  • Table 82: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Congenital Diaphragmatic Hernia Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Congenital Diaphragmatic Hernia Drugs Market, Sub-Segmentation Of Posterolateral Bochdalek Hernia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Congenital Diaphragmatic Hernia Drugs Market, Sub-Segmentation Of Anterior Morgagni Hernia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Congenital Diaphragmatic Hernia Drugs Market, Sub-Segmentation Of Hiatal Hernia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Congenital Diaphragmatic Hernia Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Congenital Diaphragmatic Hernia Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Congenital Diaphragmatic Hernia Drugs Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Pfizer Inc. Financial Performance
  • Figure 79: Johnson and Johnson Limited Financial Performance
  • Figure 80: Merck and Co. Inc. Financial Performance
  • Figure 81: AbbVie Inc. Financial Performance
  • Figure 82: Novartis AG Financial Performance

Strategic Growth Drivers Shaping the Nutraceutical Excipients Market Outlook 2025- 2034:The Role Of Health And Wellness In Driving Growth In The Nutraceutical Excipients Market

Read More About Strategic Growth Drivers Shaping the Nutraceutical Excipients Market Outlook 2025- 2034:The Role Of Health And Wellness In Driving Growth In The Nutraceutical Excipients Market

Emerging Growth Drivers in the Opioids Market Landscape: Growing Surgical Procedures Fueling Demand In The Opioids Market

Read More About Emerging Growth Drivers in the Opioids Market Landscape: Growing Surgical Procedures Fueling Demand In The Opioids Market

Osimertinib Drugs Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Read More About Osimertinib Drugs Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Otic Drugs Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Read More About Otic Drugs Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Drugs for Immunotherapy Global Market Report 2025 – By Type (Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types), By Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, I...

View Report

Immuno-Oncology Drugs Global Market Report 2025 – By Type (Immune Checkpoint Inhibitors, Immune System Modulators, Other Monoclonal Antibodies, Cancer Vaccines, Others), By Therapeutic Application (Melanoma, Lung Cancer,...

View Report

Multiple Sclerosis Drugs Global Market Report 2025 – By Drug Class (Immunomodulators, Immunosuppressants, Interferons, Other Drug Classes), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Stores), By...

View Report

Oral Biologics & Biosimilar Drugs Global Market Report 2025 – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, Arthritis,...

View Report

Orphan Drugs Global Market Report 2025 – By Therapy Area (Oncology, Blood, Central Nervous System, Endocrine, Cardiovascular, Respiratory, Immunomodulatory), By Diseases Type (Oncology, Hematology, Neurology, Cardiovascu...

View Report

Acne Drugs Global Market Report 2025 – By Type (Inflammatory Acne Drugs, Non-Inflammatory Acne Drugs), By Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Other Therapeutics), By End User (Hos...

View Report

Anemia And Other Blood Disorder Drugs Global Market Report 2025 – By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia), By Route of Administration (Oral, Injectable), By Di...

View Report

Anti-Asthmatics And COPD Drugs Global Market Report 2025 – By Drug Class (Bronchodilators, Anti-Inflammatory Drugs, Monoclonal Antibodies, Combination Drugs), By Distribution Channel (Hospital Pharmacies, General Pharmac...

View Report

Frequently Asked Questions

Congenital diaphragmatic hernia (CDH) is a rare condition that occurs when there is a hole in the diaphragm, the muscle that separates the chest from the abdomen. Congenital diaphragmatic hernia (CDH) drugs refer to the medications used in the treatment of Congenital diaphragmatic hernia and help reduce the severity of the disease and manage the symptoms and complications associated with the disease. For further insights on this market, request a sample here

The market major growth driver - Elevated Birth Defect Rates Fuel Growth In The Congenital Diaphragmatic Hernia Drug Market. For further insights on this market, request a sample here

The congenital diaphragmatic hernia drugs market size has grown strongly in recent years. It will grow from $4.38 billion in 2024 to $4.69 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to high incidence of congenital diaphragmatic hernia cases, increasing awareness of congenital diaphragmatic hernia, government initiatives. The congenital diaphragmatic hernia drugs market size is expected to see strong growth in the next few years. It will grow to " $6.25 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to growing healthcare expenditure, rare disease incentives, growing patient advocacy groups, regenerative medicine, targeted therapies. Major trends in the forecast period include advancements in medical research, advancements in drug development, advances in fetal surgery, pharmacological lung growth, increasing use of personalized medicine, development of new and innovative drug delivery systems, digital health technologies. For further insights on this market, request a sample here

The congenital diaphragmatic hernia drugs market covered in this report is segmented –
1) By Type: Posterolateral Bochdalek Hernia, Anterior Morgagni Hernia, Hiatal Hernia
2) By Treatment: Extracorporeal Membrane Oxygenation, Other Treatments
3) By Diagnosis: Prenatal, Postnatal
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End Users Subsegments:
1) By Posterolateral Bochdalek Hernia: Surgical Interventions, Medications for Symptoms
2) By Anterior Morgagni Hernia: Surgical Interventions, Medications for Symptoms
3) By Hiatal Hernia: Surgical Interventions, Medications For further insights on this market, request a sample here

North America was the largest region in the congenital diaphragmatic hernia drugs market in 2024. The regions covered in congenital diaphragmatic hernia drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the congenital diaphragmatic hernia drugs market are Pfizer Inc., Johnson and Johnson Limited, Merck and Co. Inc., AbbVie Inc., Novartis AG, GlaxoSmithKline PLC, Medtronic PLC, Amgen Inc., Becton, Dickinson and Company, Viatris Inc., B. Braun SE, Sun Pharmaceutical Industries Ltd., C.R. Bard Inc., W. L. Gore & Associates, Chiesi Farmaceutici S.p.A., Getinge AB, Ferring Pharmaceuticals, Mallinckrodt Pharmaceuticals, Integra LifeSciences Corporation, Genentech Inc., LifeCell International Private Limited, Cook Biotech Inc., Cousin Biotech SAS, Dipro Medical Devices S.R.L., Aspide Medical.. For further insights on this market, request a sample here.

Major trends in this market include Innovative Coating Technology Revolutionizes Congenital Diaphragmatic Hernia Treatment. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Congenital Diaphragmatic Hernia Drugs Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top